FDA approves Suboxone generics from Mylan, Dr. Reddy

FDA approved two generic buprenorphine/naloxone sublingual film products from Mylan N.V. (NASDAQ:MYL) and Dr. Reddy's Laboratories Ltd. (NYSE:RDY), respectively, to treat opioid dependence. FDA said they are the first approved generic versions of Suboxone sublingual film from Indivior plc (LSE:INDV).

The agency said the approvals are part of FDA's plan to encourage access and wider use of medication-assisted treatment (MAT) for opioid use disorder...